Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BOOK OF ABSTRACTS | HEALTH EQUITY
BOOKS OF ABSTRACTS | HEALTH EQUITY
Brief Research Article | HIV and AIDS
COMMENTARY
COMMENTARY | CHLAMYDIA
COMMENTARY | COVID-19 AND HIV/AIDS
COMMENTARY | COVID-19 VACCINE
COMMENTARY | DIGITAL HEALTH
COMMENTARY | EMERGENCY PRACTICE
COMMENTARY | HIV Testing
COMMENTARY | MALARIA
COMMENTARY | MATERNAL HEALTH
COMMENTARY | MATERNAL MORTALITY
COMMENTARY | MONKEYPOX
COMMENTARY | PERINATAL HIV TRANSMISSION
Editorial
EDITORIAL | POSTPARTUM HEMORRHAGE PREVENTION
LETTER TO EDITOR | INTERTRIGINOUS DERMATITIS
LETTER TO THE EDITOR | COVID-19 PANDEMIC
LETTER TO THE EDITOR | COVID-19 TEST
METHODOLOGY ARTICLE
METHODOLOGY ARTICLE | HIV
NARRATIVE REVIEW | MATERNAL HEALTH
NOTES FROM THE FIELD | COVID-19 PANDEMIC
NOTES FROM THE FIELD | MCH STUDENT ASSOCIATION
Original Article
ORIGINAL ARTICLE | ADOLESCENT HEALTH
ORIGINAL ARTICLE | AMERICAN INDIAN AND ALASKA NATIVE HEALTH
ORIGINAL ARTICLE | ANTENATAL CARE SERVICES
ORIGINAL ARTICLE | BIRTH INTERVAL
ORIGINAL ARTICLE | CAFFEINE AND CHILDHOOD OBESITY
ORIGINAL ARTICLE | CERVICAL PRECANCER
ORIGINAL ARTICLE | CHILD HEALTH
ORIGINAL ARTICLE | CHILD HEALTHCARE
ORIGINAL ARTICLE | CLUBFOOT
ORIGINAL ARTICLE | COMPLEMENTARY FEEDING PRACTICES
ORIGINAL ARTICLE | CONTINUUM OF CARE
ORIGINAL ARTICLE | COVID-19 DISEASE
ORIGINAL ARTICLE | COVID-19 IN PREGNANCY
ORIGINAL ARTICLE | COVID-19 OUTCOMES
ORIGINAL ARTICLE | DEPRESSION & HIV
ORIGINAL ARTICLE | DIETARY MICRONUTRIENTS AND HIV
Original Article | Female Sexual Dysfunction
ORIGINAL ARTICLE | HEALTHCARE SERVICES
ORIGINAL ARTICLE | HEAT-STABLE CARBETOCIN
ORIGINAL ARTICLE | HEAT-STABLE CARBETOCIN, PUBLIC-PRIVATE PARTNERSHIP
ORIGINAL ARTICLE | HEAT-STABLE CARBETOCIN, TRANEXAMIC ACID
ORIGINAL ARTICLE | HIV
ORIGINAL ARTICLE | HIV AND PREGNANT WOMEN
ORIGINAL ARTICLE | HIV INFECTION
ORIGINAL ARTICLE | HIV PREVENTION
ORIGINAL ARTICLE | HIV SCREENING
ORIGINAL ARTICLE | HIV TESTING
ORIGINAL ARTICLE | HIV Viral Load
ORIGINAL ARTICLE | HIV-TB CO-INFECTIONS
ORIGINAL ARTICLE | HIV/AIDS
ORIGINAL ARTICLE | HIV/AIDS IN ECUADOR
ORIGINAL ARTICLE | HOME DELIVERY
ORIGINAL ARTICLE | HOUSING AND HOUSING INEQUALITIES
ORIGINAL ARTICLE | IMMUNIZATION
ORIGINAL ARTICLE | IMMUNIZATION COVERAGE
ORIGINAL ARTICLE | INFLAMMATORY BOWEL DISEASE
ORIGINAL ARTICLE | LEISHMANIASIS
ORIGINAL ARTICLE | LIFE EXPECTANCY
ORIGINAL ARTICLE | MALARIA & HIV
ORIGINAL ARTICLE | MATERNAL HEALTH
ORIGINAL ARTICLE | MATERNAL HEALTH SERVICES
ORIGINAL ARTICLE | MATERNAL MORTALITY
ORIGINAL ARTICLE | MATERNAL OBESITY
ORIGINAL ARTICLE | MCH HEALTHCARE SERVICES
ORIGINAL ARTICLE | MORTALITY
ORIGINAL ARTICLE | MOTHER-TO-CHILD TRANSMISSION
ORIGINAL ARTICLE | NEONATAL MORTALITY
ORIGINAL ARTICLE | OBSTETRIC FISTULA REPAIR
ORIGINAL ARTICLE | OXYTOCIN VS MISOPROSTOL IN PPH
ORIGINAL ARTICLE | PEDIATRIC HIV
ORIGINAL ARTICLE | PERIODONTITIS
ORIGINAL ARTICLE | POSTPARTUM HEMORRHAGE
ORIGINAL ARTICLE | POSTPARTUM HEMORRHAGE MANAGEMENT
ORIGINAL ARTICLE | PPH IN HUMANITARIAN SETTINGS
ORIGINAL ARTICLE | PPH STUDY IN KENYA
ORIGINAL ARTICLE | PPH STUDY IN UGANDA
ORIGINAL ARTICLE | PRE-ECLAMPSIA
ORIGINAL ARTICLE | PREGNANCY
ORIGINAL ARTICLE | PRENATAL CARE
ORIGINAL ARTICLE | PUERPERAL SEPSIS
ORIGINAL ARTICLE | REPRODUCTIVE HEALTH
ORIGINAL ARTICLE | TEENAGE PREGNANCY
ORIGINAL ARTICLE | VACCINATION
ORIGINAL ARTICLE | VACCINE
ORIGINAL ARTICLE | VACCINE EQUITY
ORIGINAL ARTICLE | VIRTUAL PRENATAL CARE
ORIGINAL ARTICLE | WOMEN HEALTH
ORIGINAL ARTICLE | WOMEN’S HEALTH
ORIGINAL ARTICLE | YOUTH MORTALITY
Original Research | Article Healthcare
ORIGINAL RESEARCH ARTICLE | PEDIATRIC HIV
Perspective | Telehealth
PROTOCOL | PREGNANCY
PUBLIC HEALTH PRACTICE | ACADEMIC DETAILING
PUBLIC HEALTH PRACTICE | CHILD DEVELOPMENT
PUBLIC HEALTH PRACTICE | CHILD HEALTH
PUBLIC HEALTH PRACTICE | HIV
PUBLIC HEALTH PRACTICE | MATERNAL HEALTH
PUBLIC HEALTH PRACTICE | OPT-OUT APPROACH IN HIV TESTING
PUBLIC HEALTH PRACTICE | PREGNANCY WHEEL
PUBLIC HEALTH PRACTICE | SURVEILLANCE
RESEARCH COMMENTARY
Review Article
SHORT RESEARCH COMMUNICATION
SHORT RESEARCH COMMUNICATION | COVID AND MENTAL HEALTH
SHORT RESEARCH COMMUNICATION | COVID MCH RESEARCH AGENDA
SHORT RESEARCH COMMUNICATION | COVID-19
SHORT RESEARCH COMMUNICATION | COVID-19 AND CHILD VACCINATION
SHORT RESEARCH COMMUNICATION | COVID-19 AND MATERNAL MORTALITY
SHORT RESEARCH COMMUNICATION | COVID-19 AND REMOTE WORKERS
SHORT RESEARCH COMMUNICATION | COVID-19 PANDEMIC DISPARITIES
SHORT RESEARCH COMMUNICATION | HEALTHCARE PROVIDER TRAINING
SHORT RESEARCH COMMUNICATION | MALARIA
SHORT RESEARCH COMMUNICATION | SINGLETONS, TWINS, MULTIPLE BIRTHS
SHORT RESEARCH COMMUNICATION | SURVEILLANCE SYSTEM FOR COVID-19
SHORT RESEARCH COMMUNICATION | WOMEN’S HEALTH
SYSTEMATIC REVIEW
SYSTEMATIC REVIEW ARTICLE | UTI AND PULMONARY INJURY
WAME STATEMENT
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BOOK OF ABSTRACTS | HEALTH EQUITY
BOOKS OF ABSTRACTS | HEALTH EQUITY
Brief Research Article | HIV and AIDS
COMMENTARY
COMMENTARY | CHLAMYDIA
COMMENTARY | COVID-19 AND HIV/AIDS
COMMENTARY | COVID-19 VACCINE
COMMENTARY | DIGITAL HEALTH
COMMENTARY | EMERGENCY PRACTICE
COMMENTARY | HIV Testing
COMMENTARY | MALARIA
COMMENTARY | MATERNAL HEALTH
COMMENTARY | MATERNAL MORTALITY
COMMENTARY | MONKEYPOX
COMMENTARY | PERINATAL HIV TRANSMISSION
Editorial
EDITORIAL | POSTPARTUM HEMORRHAGE PREVENTION
LETTER TO EDITOR | INTERTRIGINOUS DERMATITIS
LETTER TO THE EDITOR | COVID-19 PANDEMIC
LETTER TO THE EDITOR | COVID-19 TEST
METHODOLOGY ARTICLE
METHODOLOGY ARTICLE | HIV
NARRATIVE REVIEW | MATERNAL HEALTH
NOTES FROM THE FIELD | COVID-19 PANDEMIC
NOTES FROM THE FIELD | MCH STUDENT ASSOCIATION
Original Article
ORIGINAL ARTICLE | ADOLESCENT HEALTH
ORIGINAL ARTICLE | AMERICAN INDIAN AND ALASKA NATIVE HEALTH
ORIGINAL ARTICLE | ANTENATAL CARE SERVICES
ORIGINAL ARTICLE | BIRTH INTERVAL
ORIGINAL ARTICLE | CAFFEINE AND CHILDHOOD OBESITY
ORIGINAL ARTICLE | CERVICAL PRECANCER
ORIGINAL ARTICLE | CHILD HEALTH
ORIGINAL ARTICLE | CHILD HEALTHCARE
ORIGINAL ARTICLE | CLUBFOOT
ORIGINAL ARTICLE | COMPLEMENTARY FEEDING PRACTICES
ORIGINAL ARTICLE | CONTINUUM OF CARE
ORIGINAL ARTICLE | COVID-19 DISEASE
ORIGINAL ARTICLE | COVID-19 IN PREGNANCY
ORIGINAL ARTICLE | COVID-19 OUTCOMES
ORIGINAL ARTICLE | DEPRESSION & HIV
ORIGINAL ARTICLE | DIETARY MICRONUTRIENTS AND HIV
Original Article | Female Sexual Dysfunction
ORIGINAL ARTICLE | HEALTHCARE SERVICES
ORIGINAL ARTICLE | HEAT-STABLE CARBETOCIN
ORIGINAL ARTICLE | HEAT-STABLE CARBETOCIN, PUBLIC-PRIVATE PARTNERSHIP
ORIGINAL ARTICLE | HEAT-STABLE CARBETOCIN, TRANEXAMIC ACID
ORIGINAL ARTICLE | HIV
ORIGINAL ARTICLE | HIV AND PREGNANT WOMEN
ORIGINAL ARTICLE | HIV INFECTION
ORIGINAL ARTICLE | HIV PREVENTION
ORIGINAL ARTICLE | HIV SCREENING
ORIGINAL ARTICLE | HIV TESTING
ORIGINAL ARTICLE | HIV Viral Load
ORIGINAL ARTICLE | HIV-TB CO-INFECTIONS
ORIGINAL ARTICLE | HIV/AIDS
ORIGINAL ARTICLE | HIV/AIDS IN ECUADOR
ORIGINAL ARTICLE | HOME DELIVERY
ORIGINAL ARTICLE | HOUSING AND HOUSING INEQUALITIES
ORIGINAL ARTICLE | IMMUNIZATION
ORIGINAL ARTICLE | IMMUNIZATION COVERAGE
ORIGINAL ARTICLE | INFLAMMATORY BOWEL DISEASE
ORIGINAL ARTICLE | LEISHMANIASIS
ORIGINAL ARTICLE | LIFE EXPECTANCY
ORIGINAL ARTICLE | MALARIA & HIV
ORIGINAL ARTICLE | MATERNAL HEALTH
ORIGINAL ARTICLE | MATERNAL HEALTH SERVICES
ORIGINAL ARTICLE | MATERNAL MORTALITY
ORIGINAL ARTICLE | MATERNAL OBESITY
ORIGINAL ARTICLE | MCH HEALTHCARE SERVICES
ORIGINAL ARTICLE | MORTALITY
ORIGINAL ARTICLE | MOTHER-TO-CHILD TRANSMISSION
ORIGINAL ARTICLE | NEONATAL MORTALITY
ORIGINAL ARTICLE | OBSTETRIC FISTULA REPAIR
ORIGINAL ARTICLE | OXYTOCIN VS MISOPROSTOL IN PPH
ORIGINAL ARTICLE | PEDIATRIC HIV
ORIGINAL ARTICLE | PERIODONTITIS
ORIGINAL ARTICLE | POSTPARTUM HEMORRHAGE
ORIGINAL ARTICLE | POSTPARTUM HEMORRHAGE MANAGEMENT
ORIGINAL ARTICLE | PPH IN HUMANITARIAN SETTINGS
ORIGINAL ARTICLE | PPH STUDY IN KENYA
ORIGINAL ARTICLE | PPH STUDY IN UGANDA
ORIGINAL ARTICLE | PRE-ECLAMPSIA
ORIGINAL ARTICLE | PREGNANCY
ORIGINAL ARTICLE | PRENATAL CARE
ORIGINAL ARTICLE | PUERPERAL SEPSIS
ORIGINAL ARTICLE | REPRODUCTIVE HEALTH
ORIGINAL ARTICLE | TEENAGE PREGNANCY
ORIGINAL ARTICLE | VACCINATION
ORIGINAL ARTICLE | VACCINE
ORIGINAL ARTICLE | VACCINE EQUITY
ORIGINAL ARTICLE | VIRTUAL PRENATAL CARE
ORIGINAL ARTICLE | WOMEN HEALTH
ORIGINAL ARTICLE | WOMEN’S HEALTH
ORIGINAL ARTICLE | YOUTH MORTALITY
Original Research | Article Healthcare
ORIGINAL RESEARCH ARTICLE | PEDIATRIC HIV
Perspective | Telehealth
PROTOCOL | PREGNANCY
PUBLIC HEALTH PRACTICE | ACADEMIC DETAILING
PUBLIC HEALTH PRACTICE | CHILD DEVELOPMENT
PUBLIC HEALTH PRACTICE | CHILD HEALTH
PUBLIC HEALTH PRACTICE | HIV
PUBLIC HEALTH PRACTICE | MATERNAL HEALTH
PUBLIC HEALTH PRACTICE | OPT-OUT APPROACH IN HIV TESTING
PUBLIC HEALTH PRACTICE | PREGNANCY WHEEL
PUBLIC HEALTH PRACTICE | SURVEILLANCE
RESEARCH COMMENTARY
Review Article
SHORT RESEARCH COMMUNICATION
SHORT RESEARCH COMMUNICATION | COVID AND MENTAL HEALTH
SHORT RESEARCH COMMUNICATION | COVID MCH RESEARCH AGENDA
SHORT RESEARCH COMMUNICATION | COVID-19
SHORT RESEARCH COMMUNICATION | COVID-19 AND CHILD VACCINATION
SHORT RESEARCH COMMUNICATION | COVID-19 AND MATERNAL MORTALITY
SHORT RESEARCH COMMUNICATION | COVID-19 AND REMOTE WORKERS
SHORT RESEARCH COMMUNICATION | COVID-19 PANDEMIC DISPARITIES
SHORT RESEARCH COMMUNICATION | HEALTHCARE PROVIDER TRAINING
SHORT RESEARCH COMMUNICATION | MALARIA
SHORT RESEARCH COMMUNICATION | SINGLETONS, TWINS, MULTIPLE BIRTHS
SHORT RESEARCH COMMUNICATION | SURVEILLANCE SYSTEM FOR COVID-19
SHORT RESEARCH COMMUNICATION | WOMEN’S HEALTH
SYSTEMATIC REVIEW
SYSTEMATIC REVIEW ARTICLE | UTI AND PULMONARY INJURY
WAME STATEMENT
View/Download PDF

Translate this page into:

SHORT RESEARCH COMMUNICATION | COVID-19
9 (
2
); 182-185
doi:
10.21106/ijma.378

Global Ranking of COVID-19-Related Mortality by Country using a Novel Pandemic Efficiency Index (PEI)

Center of Excellence in Health Equity, Training, and Research, Baylor College of Medicine, Houston, TX 77098, USA
Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX 77098, USA
Vanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, TN 37203, USA
The Center for Global Health and Health Policy, Global Health and Education Projects, Inc., Riverdale, MD 20738, USA

* Corresponding author email: Hamisu.salihu@bcm.edu

Licence

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The world is currently witnessing a dramatic disruption of everyday life owing to the rapid progression of the coronavirus disease 2019 (COVID-19) pandemic. As the pandemic evolves, there is an urgent need to better understand its epidemiology, characterize its potential impact, and identify mitigatory strategies to avert pandemic-related mortality. There is a need for a tool or algorithm to evaluate the extent to which public health policy and/or economic preparedness measures are effectively averting COVID-19 related mortality. We present a simple and yet practical epidemiological tool, the Pandemic Efficiency Index (PEI), that can be utilized globally to test the relative efficiency of measures put in place to avert death resulting from COVID-19 infection. Using the PEI and current COVID-19-related mortality, we determined that so far Germany demonstrates the highest PEI (5.1) among countries with more than 5,000 recorded cases of the infection, indicating high quality measures instituted by the country to avert death during the pandemic. Italy and France currently have the lowest COVID-19-related PEIs. Epidemics and pandemics come and go, but local, national, and global abilities to determine the efficiency of their efforts in averting deaths is critical.

Keywords

COVID-19
Pandemic Efficiency Index
PEI
Coronavirus
Mortality
Pandemic
Epidemic
Global health

1. Introduction

Towards the end of 2019, a novel respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), was first reported from Wuhan, the capital of Hubei province in the People’s Republic of China. This illness has already been assigned the name coronavirus disease-19 (COVID-19) by the World Health Organization (WHO).1 SARS-CoV-2 belongs to a family of viruses that cause a variety of symptoms that range in severity from mild cold symptoms to more severe infections, which disproportionately account for a high mortality rate among the elderly and individuals that are immunocompromised. The pandemic has now reached almost every country on the globe (at least 199 countries at the time of writing). The epidemiological variability and lethality of COVID-19 in general and specific populations have been reported.2,3 The world is currently witnessing substantial disruption of daily lives socially, psychologically and economically as a result of the progression of the COVID-19 pandemic.

As the pandemic rumbles through nations leaving behind considerable death and damaged economies, no effective treatment seems to be in sight as of now.4 Preventive measures, enveloped in public health advocacy both at the individual and societal levels, and reinforced by national regulations seem to be our best bet of shortening the life span of the pandemic. Various countries have instituted diverse policies and laws to protect their citizens as the natural history of the disease progresses. However, just as we witness differences in the degree of public health preparedness across nations, we are also subdued by the lack of simple epidemiological tools that could capture, in broad terms, the comparative effectiveness of measures put in place by different countries to mitigate the impact of the pandemic on human lives. In this paper, we present a simple epidemiological tool that could be utilized globally to test the relative efficiency of measures put in place to avert death resulting from COVID-19 infection. For simplicity, we refer to this assessment tool as the Pandemic Efficiency Index or PEI. The PEI could be used to potentially rank countries and assist in distilling best practices from those countries with optimal outcomes in a pandemic. The higher the PEI, the greater the efficiency of the country in protecting its citizens from death resulting from the COVID-19 pandemic. Using PEI, nations can learn and adapt best practices in pandemic control from each other. Nations can systematically reverse-engineer the practices that countries with higher PEI used to achieve lower Covid-19-related mortality.

2. Methods

We collected information on current details of COVID-19 cases across the globe from Worldometer.5 Worldometer is an independent company that operates a reference website acknowledged by the American Library Association as one of the best free online reference sources in the world. The website has been providing live updates on COVID-19 related total cases, new cases, deaths, recoveries and critical cases by country, territory or conveyance. Worldometer gathers and compiles the information from various sources, including newspapers, government websites, and social media such as Twitter, etc. The countries with more than 5,000 cases of Coronavirus, as of March 29, 2020 were included in this study and were classified as ‘high impact countries.’

We calculated the mortality rate by dividing the total deaths by total number of cases associated with the disease, for each high impact territory. As the disease originated in China, we used China’s mortality rate as the reference. The formula for COVID-19 Pandemic Efficiency Index (PEI) for a country X was derived as: For example, China had a total of 81,439 cases and 3,300 deaths, yielding a mortality rate of 0.0405 or 4.05%. Italy had 97,689 cases and 10,779 deaths, corresponding to a mortality rate of 0.1103 or 11.03%. Therefore, PEI is a comparative tool which uses the mortality rate of the pandemic’s country of origin as the ‘reference case.’ Lastly, we ranked the countries based on their PEIs.

3. Results

As of March 29, 2020, there were a total of 704,401 COVID-19 cases globally, 33,226 of which resulted in death, yielding a worldwide mortality rate of 4.72%. A total of 16 countries reported more than 5,000 cases of COVID-19 infections. The United States of America (USA) had the highest number of reported cases of 133,039, followed by Italy, which reported more than 97,000 cases so far. However, Italy had the highest number of reported deaths (10,779) with a PEI of 0.37. Other countries with a PEI lower than that of China included the Islamic Republic of Iran (0.59), the United Kingdom (0.64), Spain (0.48), and Netherlands (0.57).

The global ranking of high-impact countries based on COVID -19 PEI is illustrated in Figure 1. Germany, a country with the fifth largest number of cases (60,659) has so far experienced 482 deaths resulting from COVID-19 infection, and had the highest PEI (5.09) among the high impact countries. Austria with 5,672 cases had the second highest PEI of 4.09, followed by Canada (3.79) and Turkey (2.85). The USA was 6th on the list, with a PEI of 2.28. Italy and France were the countries with the lowest PEI of 0.4 and 0.3, respectively.

Global Ranking of high-impact countries based on COVID-19 Pandemic Efficiency Index (PEI)
Figure 1
Global Ranking of high-impact countries based on COVID-19 Pandemic Efficiency Index (PEI)

4. Discussion and Global Health Implications

COVID-19 is the latest global health threat confronting nations, research and medical communities, with national and global efforts applauded and criticized.6 Almost 3 months after the first confirmed case of the virus was identified in China, WHO declared the disease as a pandemic, making it the first such declaration since the 2009 H1N1 swine flu outbreak. The WHO had estimated COVID-19 mortality rate to be 3.4% about three weeks ago7. However, due to the rapid progression of the disease and differential efficiency in disease and mortality prevention across affected countries, the mortality rate had risen to 4.72% as of March 29, 2020. COVID-19 has been more deadly than the 2009 H1N1 swine flu pandemic, which registered a case fatality rate of 0.2%. For the first time since the outbreak, Wuhan in China reported no new cases on March 19th 2020, while the USA acquired the status of the country reporting the largest number of new COVID-19 infections worldwide. According to various analyses by the U.S. Centers for Disease Control and Prevention (CDC), older adults and those with underlying comorbidities like heart disease, lung disease or diabetes are more vulnerable to the severe forms of COVID-19 and to die from the disease.8 From our results, we observed that citizens of countries that performed worse on our PEI scale (i.e., had low PEI) such as Italy, Spain, UK etc. had a higher median age than their counterparts from other parts of the world. What was most surprising was the low mortality rate (0.79%) and the highest PEI (5.09) of Germany, in spite of the fact that it ranks 4th in the world for the highest median age.9 Austria and Portugal were the other two countries with a high PEI and median age above 44 years.

PEI is an innovative tool to compare countries in terms of the impact of their disaster preparedness and management protocols. Although COVID-19 is a global affliction, different countries have adopted different approaches to confronting the pandemic. PEI represents a simple and intuitive epidemiologic tool to compare the efficiency of policies and strategies that various countries have been adopting to curtail the impact of the COVID-19 pandemic. Lessons learned from these natural experiments would allow us to identify effective measures against mortality from countries with high PEI. Due to pandemic dynamics with numbers constantly changing, it is possible that the final PEI will only be available by the end of the current pandemic.

Acknowledgement:

None.

Compliance with Ethical Considerations

Conflicts of Interest: The authors report no conflict of interest.

Funding/Support: None.

Ethical Approval: Study used publicly available data and was not subject to IRB approval.

References

  1. . Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(COVID-2019)-and-the-virus-that-causes-it
  2. , , , , . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. New England Journal of Medicine. 2020;382:1199-1207.
    [Google Scholar]
  3. , , , , , , . SARS-CoV-2 Infection in Children. New England Journal of Medicine 2020 Mar 18 DOI:10.1056/NEJMc2005073
    [Google Scholar]
  4. , , , , , . A trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe COVID-19. New England Journal of Medicine 2020 Mar 18 doi:10.1056/NEJMoa2001282
    [Google Scholar]
  5. COVID-19 Coronavirus Pandemic. https://www.worldometers.info/coronavirus/
  6. , , , . Covid-19-Navigating the Uncharted. New England Journal of Medicine. 2020;382:1268-1269.
    [Google Scholar]
  7. . . That Doesn't Tell the Whole Story. https://time.com/5798168/coronavirus-mortality-rate/ Accessed March 29
  8. . Are You at Higher Risk for Severe Illness? https://www.cdc.gov/coronavirus/2019-ncov/specific-groups/high-risk-complications.html.
  9. Central Intelligence Agency. Country Comparison:Median Age https://www.cia.gov/library/publications/the-world-factbook/fields/343rank.html
Show Sections